Cer.A.T.T. Domain 3: Pharmacology (15%) - Complete Study Guide 2027

Domain 3 Overview: Pharmacology

Domain 3: Pharmacology represents 15% of the Cer.A.T.T. examination, making it one of four equally weighted domains alongside Basic Sciences and Basic Principles of Anesthesia. Understanding pharmacology is crucial for anesthesia technologists, as proper medication management directly impacts patient safety and surgical outcomes. This domain tests your knowledge of anesthetic agents, their mechanisms of action, side effects, and appropriate handling procedures.

The pharmacology domain covers essential medication categories used in anesthesia practice, from volatile anesthetics to emergency medications. As outlined in our comprehensive Cer.A.T.T. Exam Domains guide, this domain requires both theoretical knowledge and practical understanding of how these medications are used in clinical settings.

Anesthetic Agents Overview

Anesthetic agents form the foundation of pharmacological knowledge for anesthesia technologists. These medications are broadly categorized into inhalational and intravenous agents, each with distinct properties, administration methods, and clinical applications.

Classification Systems

Understanding drug classification helps organize pharmacological knowledge effectively:

• Volatile Anesthetics: Sevoflurane, Isoflurane, Desflurane
• Intravenous Induction Agents: Propofol, Etomidate, Ketamine
• Barbiturates: Thiopental, Methohexital
• Benzodiazepines: Midazolam, Lorazepam, Diazepam
• Opioids: Fentanyl, Morphine, Remifentanil, Sufentanil

Each classification requires understanding of onset times, duration of action, metabolism pathways, and elimination routes. This knowledge directly relates to proper handling and preparation procedures that anesthesia technologists must master.

Inhalational Anesthetics

Inhalational anesthetics represent a critical category within Domain 3, requiring detailed knowledge of vapor delivery systems, minimum alveolar concentration (MAC) values, and storage requirements.

Sevoflurane

Sevoflurane is the most commonly used volatile anesthetic in modern practice. Key characteristics include:

• MAC Value: 2.0% in healthy adults
• Blood/Gas Coefficient: 0.65 (rapid onset/offset)
• Storage: Room temperature, protected from light
• Metabolism: 2-3% hepatic metabolism
• Special Considerations: Compatible with CO2 absorbents

Isoflurane

Isoflurane remains widely used with distinct properties:

• MAC Value: 1.15% in healthy adults
• Blood/Gas Coefficient: 1.4 (moderate onset/offset)
• Cardiovascular Effects: Minimal myocardial depression
• Respiratory Effects: Bronchodilation properties

Desflurane

Desflurane presents unique handling challenges:

• MAC Value: 6.0% in healthy adults
• Boiling Point: 23.5°C (requires heated vaporizer)
• Blood/Gas Coefficient: 0.42 (fastest onset/offset)
• Environmental Impact: High global warming potential

Intravenous Anesthetics

Intravenous anesthetic agents require precise preparation, proper storage conditions, and understanding of stability factors. These medications often have specific mixing requirements and limited stability once prepared.

Propofol

Propofol is the most commonly used intravenous induction agent:

Property	Value	Clinical Significance
Onset Time	30-45 seconds	Rapid induction
Duration	5-10 minutes	Requires continuous infusion
Elimination	Hepatic metabolism	Context-sensitive half-time
Storage	Room temperature	Discard after 6 hours if opened
Formulation	Lipid emulsion	Supports bacterial growth

Etomidate

Etomidate offers cardiovascular stability during induction:

• Mechanism: GABA-A receptor agonist
• Onset: 30-60 seconds
• Duration: 3-5 minutes
• Advantage: Minimal cardiovascular depression
• Disadvantage: Adrenal suppression with continuous infusion
• Storage: Room temperature, protect from freezing

Ketamine

Ketamine provides unique anesthetic properties:

• Mechanism: NMDA receptor antagonist
• Classification: Controlled substance (Schedule III)
• Onset: 1-2 minutes IV, 3-4 minutes IM
• Special Properties: Maintains respiratory drive
• Side Effects: Emergence phenomena, increased salivation

Neuromuscular Blocking Agents

Neuromuscular blocking agents (NMBAs) require careful handling and understanding of onset times, duration, and reversal options. These medications are critical for surgical relaxation and airway management.

Depolarizing Agents

Succinylcholine remains the only commonly used depolarizing NMBA:

• Onset: 45-60 seconds
• Duration: 5-10 minutes
• Storage: Refrigeration required (2-8°C)
• Metabolism: Plasma cholinesterases
• Contraindications: Malignant hyperthermia susceptibility, hyperkalemia

Non-Depolarizing Agents

Non-depolarizing NMBAs offer more predictable duration and reversal options:

Agent	Onset (min)	Duration (min)	Elimination	Storage
Vecuronium	2-3	30-45	Hepatic	Refrigerate reconstituted
Rocuronium	1-2	30-60	Hepatic/Renal	Room temperature
Atracurium	2-3	20-35	Hoffman elimination	Refrigerate
Cisatracurium	2-3	25-40	Hoffman elimination	Refrigerate

Reversal Agents

Understanding reversal agents is crucial for anesthesia technologists, as these medications ensure safe recovery from anesthesia. Recent additions like sugammadex have revolutionized neuromuscular blockade reversal.

Anticholinesterases

Traditional reversal agents work by inhibiting acetylcholinesterase:

• Neostigmine: Most commonly used, requires anticholinergic co-administration
• Edrophonium: Rapid onset, shorter duration
• Pyridostigmine: Longer duration of action

Sugammadex

Sugammadex represents a breakthrough in neuromuscular reversal:

• Mechanism: Selective relaxant binding agent (gamma-cyclodextrin)
• Specificity: Rocuronium and vecuronium
• Onset: 2-3 minutes for complete reversal
• Storage: Room temperature
• Dosing: Weight-based, varies by depth of blockade

Cardiovascular Medications

Cardiovascular medications frequently encountered in anesthesia practice include vasopressors, antiarrhythmics, and antihypertensives. Understanding their mechanisms and preparation requirements is essential for exam success.

Vasopressors

Common vasopressors require specific dilution and administration protocols:

• Epinephrine: Alpha and beta agonist, multiple concentrations available
• Norepinephrine: Primarily alpha agonist, requires central line administration
• Phenylephrine: Pure alpha agonist, can be given peripherally
• Ephedrine: Mixed-acting sympathomimetic, suitable for obstetric use
• Vasopressin: ADH analog, useful in refractory shock

Beta Blockers

Beta blockers used in perioperative settings include:

• Propranolol: Non-selective beta blocker
• Metoprolol: Beta-1 selective
• Esmolol: Ultra-short acting, ideal for intraoperative use
• Labetalol: Combined alpha and beta blockade

Emergency Drugs

Emergency medications must be immediately available and properly stored. Understanding indications, dosing, and preparation is critical for patient safety and exam success.

Malignant Hyperthermia Protocol

Dantrolene preparation and administration requirements:

• Initial Dose: 2.5 mg/kg IV bolus
• Preparation: 20 mg vial requires 60 mL sterile water
• Storage: Room temperature, multiple vials needed
• Mixing: Vigorous agitation required, difficult to dissolve
• Stability: Use within 6 hours of reconstitution

Local Anesthetic Toxicity

Intralipid (20% lipid emulsion) for LAST treatment:

• Initial Bolus: 1.5 mL/kg lean body weight
• Infusion Rate: 0.25 mL/kg/min
• Maximum Dose: 12 mL/kg total
• Storage: Room temperature

Local Anesthetics

Local anesthetics are fundamental to anesthesia practice, requiring knowledge of chemical classes, maximum safe doses, and onset characteristics. The two main chemical classes have distinct properties and allergic potential.

Ester Local Anesthetics

Ester local anesthetics are metabolized by plasma cholinesterases:

Agent	Maximum Dose (mg/kg)	Onset	Duration	Notes
Procaine	10	Slow	Short	High allergic potential
Chloroprocaine	15	Fast	Short	Rapid metabolism
Tetracaine	1.5	Slow	Long	High potency

Amide Local Anesthetics

Amide local anesthetics undergo hepatic metabolism:

Agent	Maximum Dose (mg/kg)	Onset	Duration	Clinical Use
Lidocaine	5 (7 with epi)	Fast	Moderate	Most versatile
Bupivacaine	2.5 (3 with epi)	Slow	Long	High cardiotoxicity
Ropivacaine	3	Moderate	Long	Reduced cardiotoxicity
Mepivacaine	5	Fast	Moderate	No vasodilatation

As discussed in our comprehensive Cer.A.T.T. study guide, understanding maximum safe doses is critical for preventing local anesthetic systemic toxicity (LAST), a potentially life-threatening complication.

Drug Interactions

Understanding clinically significant drug interactions is essential for anesthesia technologists. These interactions can affect drug efficacy, increase toxicity, or require dosage adjustments.

Common Anesthetic Interactions

• Succinylcholine + Pseudocholinesterase deficiency: Prolonged paralysis
• Volatile anesthetics + Non-depolarizing NMBAs: Enhanced neuromuscular blockade
• Propofol + Opioids: Synergistic respiratory depression
• Ketamine + Benzodiazepines: Reduced emergence phenomena

Medication Compatibility

Understanding which medications can be mixed or administered through the same IV line prevents precipitation and maintains drug stability:

• Compatible: Propofol with lidocaine (reduces injection pain)
• Incompatible: Thiopental with muscle relaxants (precipitation)
• Incompatible: Diazepam with most other medications (precipitation)

Dosage Calculations

Dosage calculations represent a critical component of pharmacology knowledge. Understanding weight-based dosing, concentration calculations, and infusion rates ensures patient safety.

Common Calculation Types

• Weight-based dosing: Most anesthetic medications
• Concentration calculations: Diluting concentrated solutions
• Infusion rate calculations: Continuous medication delivery
• Unit conversions: mg to mcg, mL to L

Practice with realistic scenarios helps build confidence. Many candidates find that consistent practice with quality practice questions significantly improves calculation speed and accuracy.

Study Strategies for Domain 3

Effective pharmacology preparation requires systematic approach and regular practice. Understanding the depth of knowledge required, as outlined in our analysis of Cer.A.T.T. exam difficulty, helps focus study efforts appropriately.

Recommended Study Approach

1. Create drug classification charts: Organize medications by mechanism and clinical use
2. Practice dosage calculations daily: Build speed and accuracy with repetitive practice
3. Use flashcards for onset/duration times: Memorize key pharmacokinetic parameters
4. Focus on storage requirements: Understand temperature and stability requirements
5. Review emergency protocols: Memorize critical medication dosing and preparation

Consider the broader context of your certification journey by reviewing our analysis of Cer.A.T.T. certification value to maintain motivation during intensive study periods.

Memory Techniques

• Mnemonics: Create memorable phrases for drug classifications
• Association: Link drug properties to clinical scenarios
• Visualization: Picture medication vials and preparation techniques
• Repetition: Regular review of key concepts and calculations

Understanding how Domain 3 connects with other exam areas, particularly Domain 1: Equipment and Instrumentation, helps create comprehensive knowledge that supports overall exam success.